تاثیر هشت هفته تمرین مقاومتی همراه با مصرف ویتامین D بر سطوح کمرین و امنتین-1 در افراد مبتلا به دیابت نوع2

1. Abeer, A., & Suzan, M. M. (2019). Vitamin D Supplementation Reduces Serum Chemerin Level in Gestational Diabetes Mellitus Rat Model. The Medical Journal of Cairo University, 87, 3069-3080.
2. Al-Daghri, N. M., Alkharfy, K. M., Al-Othman, A., El-Kholie, E., Moharram, O., Alokail, M. S., ... & Chrousos, G. P. (2012). Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovascular diabetology, 11(1), 1-7.
3. Aminilari, Z., Daryanoosh, F., Koshkie Jahromi, M., & Mohammadi, M. (2014). The effect of 12 weeks aerobic exercise on the apelin, omentin and glucose in obese older women with diabetes type 2. Journal of Arak University of Medical Sciences, 17(4), 1-10.
4. Astrup, A., & Finer, N. (2000). Redefining type 2 diabetes:‘diabesity’or ‘obesity dependent diabetes mellitus’?. obesity reviews, 1(2), 57-59.
5. Booth, A., Magnuson, A., Fouts, J., & Foster, M. T. (2016). Adipose tissue: an endocrine organ playing a role in metabolic regulation. Hormone molecular biology and clinical investigation, 26(1), 25-42.
6. Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., Collier, G., ... & Segal, D. (2007). Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 148(10), 4687-4694.
7. Bronas, U. G., Treat-Jacobson, D., & Painter, P. (2009). Alternative forms of exercise Training as complementary therapy in the prevention and management of Type 2 Diabetes. Diabetes Spectrum, 22(4), 220-225.
8. Burr, J. F., Rowan, C. P., Jamnik, V. K., & Riddell, M. C. (2010). The role of physical activity in type 2 diabetes prevention: physiological and practical perspectives. The Physician and sportsmedicine, 38(1), 72-82.
9. Cavalier, E., Delanaye, P., Souberbielle, J. C., & Radermecker, R. P. (2011). Vitamin D and type 2 diabetes mellitus: where do we stand? Diabetes & metabolism, 37(4), 265-272.
10. Ding, C., Gao, D., Wilding, J., Trayhurn, P., & Bing, C. (2012). Vitamin D signalling in adipose tissue. British Journal of Nutrition, 108(11), 1915-1923.
11. Dunlop, T. W., Väisänen, S., Frank, C., Molnar, F., Sinkkonen, L., & Carlberg, C. (2005). The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α, 25-dihydroxyvitamin D3 and its nuclear receptor. Journal of molecular biology, 349(2), 248-260.
12. El‐Mesallamy, H. O., El‐Derany, M. O., & Hamdy, N. M. (2011). Serum omentin‐1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabetic Medicine, 28(10), 1194-1200.
13. Fazelian, S., Paknahad, Z., Khajehali, L., Kheiri, S., & Amani, R. (2018). The effects of supplementation with vitamin D on inflammatory biomarkers, omentin, and vaspin in women with type 2 diabetes: A randomized double‐blind placebo‐controlled clinical trial. Journal of food biochemistry, 42(6), e12631.
14. Galdavi, R., & Mogharnasi, M. (2016). The effect of two methods of endurance and resistance training on omentin-1 levels of plasma and factors related to obesity in overweight and obese girls in university of Sistan and Baluchestan. Iranian Journal of Diabetes and Metabolism, 15(2), 101-109.
15. Glass, C. K., & Olefsky, J. M. (2012). Inflammation and lipid signaling in the etiology of insulin resistance. Cell metabolism, 15(5), 635-645.
16. Gürsoy, G., Kırnap, N. G., Eşbah, O., Acar, Y., Demirbaş, B., Akçayöz, S., & Öztürk, A. (2010). The relationship between plasma omentin-1 levels and insulin resistance in newly diagnosed type 2 diabetıc women. Clinical reviews and opinions, 2(4), 49-54.

17. Hafshjani, N. A., Minasian, V. (2019). Changes in plasma levels of omentin-1, CRP and aerobic capacity after exercise interventions in overweight and obese women. 2 (11): 63-74.
18. Halabis, M., Dziedzic, M., Warchulinska, J., Kaznowska-Bystryk, I., & Solski, J. (2015). Omentin-a new adipokine with many roles to play. Current Issues in Pharmacy and Medical Sciences, 28(3), 176-180.
19. Hameed, I., Masoodi, S. R., Mir, S. A., Nabi, M., Ghazanfar, K., & Ganai, B. A. (2015). Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World journal of diabetes, 6(4), 598-612.
20. Herder, C., Kannenberg, J. M., Niersmann, C., Huth, C., Carstensen-Kirberg, M., Wittenbecher, C., ... & Thorand, B. (2017). Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. European journal of endocrinology, 177(4), 277-286.
21. Kadoglou, N. P., Fotiadis, G., Athanasiadou, Z., Vitta, I., Lampropoulos, S., & Vrabas, I. S. (2012). The effects of resistance training on ApoB/ApoA-I ratio, Lp (a) and inflammatory markers in patients with type 2 diabetes. Endocrine, 42(3), 561-569.
22. Kang, S., Woo, J. H., Shin, K. O., Kim, D., Lee, H. J., Kim, Y. J., & Yeo, N. H. (2009). Circuit resistance exercise improves glycemic control and adipokines in females with type 2 diabetes mellitus. Journal of sports science & medicine, 8(4), 682.
23. Kim, H. J., Kang, C. K., Park, H., & Lee, M. G. (2014). Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women. Journal of exercise nutrition & biochemistry, 18(3), 249-57.
24. Kim, S. H., Lee, S. H., Ahn, K. Y., Lee, D. H., Suh, Y. J., Cho, S. G., ... & Nam, M. (2014). Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clinical endocrinology, 80(6), 825-833.
25. Lehrke, M., Becker, A., Greif, M., Stark, R., Laubender, R. P., von Ziegler, F., ... & Broedl, U. C. (2009). Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European journal of endocrinology, 161(2), 339.
26. Madsen, S. M., Thorup, A. C., Bjerre, M., & Jeppesen, P. B. (2015). Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome? Archives of physiology and biochemistry, 121(4), 129-138.
27. Moreno‐Navarrete, J. M., Ortega, F., Castro, A., Sabater, M., Ricart, W., & Fernández‐Real, J. M. (2011). Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity, 19(8), 1552-1559.
28. Neuparth, M. J., Proença, J. B., Santos-Silva, A., & Coimbra, S. (2014). The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus. Journal of Investigative Medicine, 62(2), 350-353.
29. No, S. A. J. G., Fathi, M., Hejazi, K., & Ziayi, M. (2017). The effects of eight weeks of aerobic interval exercise on omentin-1, resistin, and adiponectin in elderly men with type 2 diabetes. Pathobiology Research., 20(3), 17-32.
30. Onishi, Y., Hayashi, T., Sato, K. K., Ogihara, T., Kuzuya, N., Anai, M., ... & Kikuchi, M. (2010). Fasting tests of insulin secretion and sensitivity predict future prediabetes in Japanese with normal glucose tolerance. Journal of diabetes investigation, 1(5), 191-195.
31. Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011). Adipokines in inflammation and metabolic disease. Nature reviews immunology, 11(2), 85-97.
32. Pan, H. Y., Guo, L., & Li, Q. (2010). Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes research and clinical practice, 88(1), 29-33.
33. Pesta, D. H., Goncalves, R. L., Madiraju, A. K., Strasser, B., & Sparks, L. M. (2017). Resistance training to improve type 2 diabetes: working toward a prescription for the future. Nutrition & metabolism, 14(1), 1-10.
34. Rahimi, N., Samavati, S. M., Goharian, A., & Heidarian, P. A. (2017). The Effect of Aerobic Exercises and 25-Hydroxy Vitamin D Supplements on Glycemic Indexes and Insulin Resistant in Males with Type 2 Diabetes. Sadra Medical Sciences Journal. 5(1): 45-56.
35. Reyman, M. V. S. A., Stuart, A. V., van Summeren, M., Rakhshandehroo, M., Nuboer, R., De Boer, F. K., ... & Schipper, H. S. (2014). Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity. International journal of obesity, 38(1), 46-52.
36. Roh, S. G., Song, S. H., Choi, K. C., Katoh, K., Wittamer, V., Parmentier, M., & Sasaki, S. I. (2007). Chemerin—a new adipokine that modulates adipogenesis via its own receptor. Biochemical and biophysical research communications, 362(4), 1013-1018.
37. Rutkowski, P., Sledzinski, T., Zielinska, H., Lizakowski, S., Goyke, E., Szrok-Wojtkiewicz, S., ... & Rutkowski, B. (2012). Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation. Regulatory peptides, 173(1-3), 55-59.
38. Saremi, A., Moslehabadi, M., & Parastesh, M. (2011). Effects of Twelve-week Strength Training on Serum Chemerin, TNF-α and CRP Level in Subjects with the Metabolic Syndrome. Iranian Journal of Endocrinology and Metabolism. 12(5): 536-543.

39. Saremi, A., Shavandi, N., Shahrjerdi, S., & Mahmoudi, Z. (2014). The effect of aerobic training with Vitamin D supplementation on cardiovascular risk factors in obese women.
40. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., ... & Lazar, M. A. (2001). The hormone resistin links obesity to diabetes. Nature, 409(6818), 307-312.
41. Su, S. C., Pei, D., Hsieh, C. H., Hsiao, F. C., Wu, C. Z., & Hung, Y. J. (2011). Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes. Acta diabetologica, 48(2), 113-119.
42. Wei, Y., Sowers, J. R., Clark, S. E., Li, W., Ferrario, C. M., & Stump, C. S. (2008). Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase. American Journal of Physiology-Endocrinology and Metabolism, 294(2), E345-E351.
43. Weigert, J., Neumeier, M., Wanninger, J., Filarsky, M., Bauer, S., Wiest, R., ... & Buechler, C. (2010). Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical endocrinology, 72(3), 342-348.
44. Yan, P., Liu, D., Long, M., Ren, Y., Pang, J., & Li, R. (2011). Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Experimental and clinical endocrinology & diabetes, 119(04), 257-263.
45. Yang, R. Z., Lee, M. J., Hu, H., Pray, J., Wu, H. B., Hansen, B. C., ... & Gong, D. W. (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American journal of physiology-endocrinology and metabolism, 290(6), E1253-E1261.
46. Yin, J., Hou, P., Wu, Z., & Nie, Y. (2015). Decreased levels of serum omentin-1 in patients with inflammatory bowel disease. Medical science monitor: international medical journal of experimental and clinical research, 21, 118-122.
47. Zanuso, S., Jimenez, A., Pugliese, G., Corigliano, G., & Balducci, S. (2010). Exercise for the management of type 2 diabetes: a review of the evidence. Acta diabetologica, 47(1), 15-22.

48. Zorlu, M. E., Kiskac, M. U., Cakirca, M. U., Karatoprak, C. U., Güler, E. M., Çelik, K, & Kocyigit, A. B. (2016). Evaluation of the relation between vitamin d and serum omentin and vaspin levels in women. Experimental and Clinical Endocrinology & Diabetes. 124(07):440-3.